A Hypomorphic Lsd1 Allele Results in Heart Development Defects in Mice

• Thomas B. Nicholson,

  Affiliations Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America, Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Anup K. Singh,

  Affiliation Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, United States of America

  ⨯
• Hui Su,

  Affiliations Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America, Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Sarah Hevi,

  Affiliations Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America, Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Jing Wang,

  Affiliation Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Jeff Bajko,

  Affiliation Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Mei Li,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Reginald Valdez,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Margaret Goetschkes,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Paola Capodieci,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Joseph Loureiro,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Xiaodong Cheng,

  Affiliation Department of Biochemistry, Emory University, Atlanta, Georgia, United States of America

  ⨯
• En Li,

  Affiliation Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Bernd Kinzel,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Mark Labow,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Taiping Chen

  * E-mail: tchen2@mdanderson.org

  Affiliations Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America, Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America, Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas, United States of America

  ⨯
• [ view all ]
• [ view less ]